For research use only. Not for therapeutic Use.
Leramistat(CAT: I040774) is a small-molecule metalloenzyme inhibitor designed to target matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases involved in the breakdown of extracellular matrix components. By inhibiting MMP activity, Leramistat helps regulate tissue remodeling, inflammation, and tumor invasion. It has been investigated for therapeutic potential in cancer, inflammatory diseases, and fibrotic disorders, where excessive MMP activity contributes to disease progression. Leramistat is a valuable research tool for studying MMP-mediated pathways and exploring strategies to modulate extracellular matrix dynamics in pathological conditions.
| CAS Number | 1642602-54-7 |
| Synonyms | 4-(4-chloro-2-cyanophenyl)-N-(4-hydroxy-4-methylcyclohexyl)benzenesulfonamide |
| Molecular Formula | C20H21ClN2O3S |
| Purity | ≥95% |
| IUPAC Name | 4-(4-chloro-2-cyanophenyl)-N-(4-hydroxy-4-methylcyclohexyl)benzenesulfonamide |
| InChI | InChI=1S/C20H21ClN2O3S/c1-20(24)10-8-17(9-11-20)23-27(25,26)18-5-2-14(3-6-18)19-7-4-16(21)12-15(19)13-22/h2-7,12,17,23-24H,8-11H2,1H3 |
| InChIKey | PHOYDFRXZMNHIF-UHFFFAOYSA-N |
| SMILES | CC1(CCC(CC1)NS(=O)(=O)C2=CC=C(C=C2)C3=C(C=C(C=C3)Cl)C#N)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
